HopeStage
Back to all studies
CompletedNCT01952041

Smartphone Monitoring and Relapse Prevention in Schizophrenia

About this titleRead the official source — NCT01952041
Behavioural studyAges 18+United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
Glen OaksSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: March 13, 2015
Recruitment status
Completed
Enrollment listed in the registry
149
Sponsor
Dartmouth-Hitchcock Medical Center
Sponsor type
Hospital / academic medical center
Study type
Behavioral
Intervention type
Behavioural
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT01952041
Official title
Show the full official title

A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Glen Oaks

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Dartmouth-Hitchcock Medical Center, a hospital or academic medical center.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies